asparagine
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Apr 30, 2024 (NCT06361329)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- AsparagineSupplementation
Asparagine supplementation
Chemistry & pharmacology
Loading structure…
SMILES
NC(=O)C[C@H](N)C(=O)O- Mol. weight
- 132.12 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL58832 ↗
Also known as
- 2-aminosuccinamic acid
- 2-aminosuccinamic acid
- 2-aminosuccinic acid
- 2-aminosuccinic acid
- (2s)-2,4-diamino-4-oxobutanoic acid
- (2s)-2,4-diamino-4-oxobutanoic acid
- (2s)-2-amino-3-carbamoylpropanoic acid
- (2s)-2-amino-3-carbamoylpropanoic acid
- alpha-aminosuccinamic acid
- alpha-aminosuccinamic acid
- asn
- asn
- asparagine
- asparagine
- asparagine
- asparagine
- asparagine
- asparagine
- asparagine
- asparagine
- aspartamic acid
- aspartamic acid
- l-2-aminosuccinamic acid
- l-2-aminosuccinamic acid
- l-asparagin
- l-asparagin
- l-aspartic acid beta-amide
- l-aspartic acid beta-amide
- l-aspartic acid β-amide
- l-aspartic acid β-amide
- n
- n
- (s)-2-amino-3-carbamoylpropanoic acid
- (s)-2-amino-3-carbamoylpropanoic acid
- (s)-asparagine
- (s)-asparagine
- α-aminosuccinamic acid
- α-aminosuccinamic acid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06361329 | Phase 3 | Apr 30, 2024 | Zhejiang University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2024 |
1 organizations
Page 1 / 1